Blood-Based Approach to PD-L1 Detection Shows Concordance with Immunohistochemistry
The investigational methodology incorporates CK19 expression to identify PD-L1 derived from activated immune cells and tumor cells.
Read More
Search Results for: lung cancer
FDA Approves First Multiplexed Companion Diagnostic for Solid Tumors
The Centers for Medicare and Medicaid Services at the same time proposed coverage of the F1CDx test from Foundation Medicine, which detects genetic mutations in 324 genes and two genomic signatures in any solid tumor type.
Read More
Roche Presents Data on Test for Measuring Tumor Mutational Burden
First data on a novel blood-based assay intended to measure tumor mutational burden were presented at the recent annual meeting of the European Society for Medical Oncology.
Read More
October 2017 Product News
This month’s issue features bioinformatics software from Dotmatics, galectin-3 reagents from BBI Solutions, and a pipette disposal system from Whitney Medical Solutions.
Read More
Biodesix Test Identifies Patients with Likely Improved Survival on Afatinib Therapy
Clinical findings have shown that the VeriStrat test from Biodesix is prognostic for outcomes among patients with squamous cell carcinoma of the lung who are treated with afatinib.
Read More